HBL Hadasit Bio Holdings Investor

HBL Hadasit Bio Holdings is the medical research center of the Hadassah University Hospital.

Invests into

Technology: Anti-infective Drugs
Industry: PharmTech
Headquarters: Jerusalem, Yerushalayim, Israel
Founded Date: 2005-01-01
Funding Status: IPO
Investor Type: Micro VC, Venture Capital
Investment Stage: Early Stage Venture
Number Of Exits: 1
Total Funding: 2000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2015-06-28
Last Funding Type: Post-IPO Equity

Visit Website
info@hbl.co.il
http://twitter.com/HadasitBio
Register and Claim Ownership